Page 52 - IMO-2-1
P. 52

Innovative Medicines & Omics                              Current approach in the management of kidney disease



               kidney disease in patients with acute kidney injury following   15.  Zuk  A,  Bonventre  JV.  Recent  advances  in  acute  kidney
               a major surgery: A US claims database analysis. Clin Kidney   injury and its consequences and impact on chronic kidney
               J. 2023;16(12):2461-2471.                          disease. Curr Opin Nephrol Hypertens. 2019;28(4):397-405.
               doi: 10.1093/ckj/sfad148                           doi: 10.1097/MNH.0000000000000504
            5.   Jager  KJ,  Kovesdy  C,  Langham  R,  Rosenberg  M,  Jha  V,   16.  Bonavia A, Singbartl K. A  review of the role of immune
               Zoccali C. A single number for advocacy and communication-  cells in acute kidney injury.  Pediatr Nephrol. 2018;33(10)
               worldwide more than 850 million individuals have kidney   :1629-1639.
               diseases. Nephrol Dial Transplant. 2019;34(11):1803-1805.
                                                                  doi: 10.1007/s00467-017-3774-5
               doi: 10.1093/ndt/gfz174
                                                               17.  Hirsch JS, Ng JH, Ross DW,  et al. Acute kidney injury
            6.   Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global   in patients hospitalized with COVID-19.  Kidney Int.
               epidemiology of diabetes and kidney disease. Adv Chronic   2020;98(1):209-218.
               Kidney Dis. 2018;25(2):121-132.
                                                                  doi: 10.1016/j.kint.2020.05.006
               doi: 10.1053/j.ackd.2017.10.011
                                                               18.  Joannidis M, Forni LG, Klein SJ,  et al. Lung-kidney
            7.   Vera M, Torramade-Moix S, Martin-Rodriguez S,  et al.   interactions in critically ill patients: Consensus report of
               Antioxidant and anti-inflammatory strategies based on   the Acute Disease Quality Initiative (ADQI) 21 Workgroup.
               the potentiation of glutathione peroxidase activity prevent   Intensive Care Med. 2020;46(4):654-672.
               endothelial dysfunction in chronic kidney disease.  Cell      doi: 10.1007/s00134-019-05869-7
               Physiol Biochem. 2019;52(5):1251-1252.
                                                               19.  Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG.
               doi: 10.1159/000495540
                                                                  Identification of a potential mechanism of acute kidney
            8.   Yu J, Mao S, Zhang Y,  et  al. MnTBAP therapy attenuates   injury during the COVID-19 outbreak: A study based on
               renal fibrosis in mice with 5/6 nephrectomy. Oxid Med Cell   single-cell transcriptome analysis.  Intensive Care Med.
               Longev. 2016;2016:7496930.                         2020;46(6):1114-1116.
               doi: 10.1155/2016/7496930                          doi: 10.1007/s00134-020-06026-1
            9.   Gaut JP, Liapis H. Acute kidney injury pathology and   20.  He W, Liu X, Hu B,  et al. Mechanisms of SARS-CoV-2
               pathophysiology: A  retrospective review.  Clin Kidney J.   infection-induced kidney injury: A literature review. Front
               2020;14(2):526-536.                                Cell Infect Microbiol. 2022;12:838213.
               doi: 10.1093/ckj/sfaa142                           doi: 10.3389/fcimb.2022.838213
            10.  Lv W, Booz GW, Fan F, Wang Y, Roman RJ. Oxidative stress   21.  Chiu PF, Su SL, Tsai CC, et al. Cyclophilin A and CD147
               and renal fibrosis: Recent insights for the development of   associate with  progression of diabetic  nephropathy.  Free
               novel therapeutic strategies. Front Physiol. 2018;9:105.  Radic Res. 2018;52(11-12):1456-1463.
               doi: 10.3389/fphys.2018.00105                      doi:10.1080/10715762.2018.1523545
            11.  Bhargava P, Schnellmann RG. Mitochondrial energetics in   22.  Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E,
               the kidney. Nat Rev Nephrol. 2017;13(10):629-646.  Zafrani L. Acute kidney injury in critically ill patients with
                                                                  COVID-19. Intensive Care Med. 2020;46(7):1339-1348.
               doi: 10.1038/nrneph.2017.107
                                                                  doi: 10.1007/s00134-020-06153-9
            12.  Morigi M, Perico L, Benigni A. Sirtuins in renal health and
               disease. J Am Soc Nephrol. 2018;29(7):1799-1809.  23.  Legrand M, Bell S, Forni L,  et al. Pathophysiology of
                                                                  COVID-19-associated acute kidney injury. Nat Rev Nephrol.
               doi: 10.1681/ASN.2017111218
                                                                  2021;17(11):751-764.
            13.  Yang B, Lan S, Dieudé M,  et al. Caspase-3 is a pivotal
               regulator of  microvascular rarefaction  and renal  fibrosis      doi: 10.1038/s41581-021-00452-0
               after ischemia-reperfusion injury.  J  Am Soc Nephrol.   24.  Faour WH, Choaib A, Issa E, et al. Mechanisms of COVID-
               2018;29(7):1900-1916.                              19-induced kidney injury and current pharmacotherapies.
                                                                  Inflamm Res. 2022;71(1):39-56.
               doi: 10.1681/ASN.2017050581
                                                                  doi: 10.1007/s00011-021-01520-8
            14.  Anders HJ, Schaefer L. Beyond tissue injury-damage-
               associated molecular patterns, toll-like receptors, and   25.  Franzén S, DiBona G, Frithiof R. Anesthesia and the renal
               inflammasomes also drive regeneration and fibrosis. J Am   sympathetic nervous system in perioperative AKI.  Semin
               Soc Nephrol. 2014;25(7):1387-1400.                 Nephrol. 2022;42(3):151283.
               doi: 10.1681/ASN.2014010117                        doi: 10.1016/j.semnephrol.2022.10.009


            Volume 2 Issue 1 (2025)                         46                               doi: 10.36922/imo.4969
   47   48   49   50   51   52   53   54   55   56   57